ANCA Vasculitis: Early Hypoxemia Is Bad Omen (CME/CE)

(MedPage Today) -- Remission more likely with rituximab than with cyclophosphamide
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news